What Happened
IBM (IBM) shares dropped more than 10% at the open on Thursday after the company’s latest quarterly results failed to give investors enough confidence that it can outrun the growing pressure AI is putting on legacy software and infrastructure names.
The stock’s decline also fit into a broader selloff across parts of enterprise software, with names like ServiceNow and Oracle also under pressure.
This was not a quarter where IBM badly missed across the board. The problem was that the report did not do enough to change the market’s current concern: that AI may be disrupting parts of IBM’s business faster than investors are comfortable with.
Software Held Up, But Consulting Did Not
The mixed nature of the quarter is what made the reaction more notable.
On the positive side, software sales grew more than expected. That should have helped reinforce IBM’s argument that its portfolio is becoming more relevant as enterprises lean further into hybrid cloud and AI-linked workloads.
But the weaker point was consulting, where revenue came in below expectations.
That matters because consulting is still an important part of the broader IBM story. If software is improving but consulting is lagging, investors are left asking whether the company’s transformation is happening fast enough to offset pressure elsewhere.
In other words, one better segment was not enough to overpower concern around another.
Guidance Looked Too Careful
Another problem was the company’s full-year outlook.
IBM maintained its guidance for constant-currency revenue growth above 5%, while Wall Street had been looking for slightly better than that. On the surface, that does not look like a major miss. But in this kind of market, cautious guidance can matter more than a decent quarter.
That is especially true because the company recently closed its Confluent acquisition, which investors would reasonably expect to add some revenue support. If IBM still chose not to move guidance more confidently higher, the market could read that as management staying conservative because visibility is not as strong as investors hoped.
That seems to be part of what happened here.
The AI Question Has Not Gone Away
The core issue hanging over IBM remains AI disruption.
Investors have been reassessing many software and infrastructure names through the same lens: will AI strengthen their products, or will it weaken their moat by replacing some of what customers already buy?
That is the right context for this stock move.
IBM has argued that AI should act as a tailwind and make its offerings more useful to clients. Management is clearly trying to frame the company as a beneficiary of enterprise AI adoption rather than a victim of it.
But the market is not fully buying that story yet.
IBM Is Still Dealing With A Mainframe Anxiety Overhang
Part of the skepticism goes back to the pressure IBM faced earlier this year.
The source notes that in February, IBM suffered its biggest monthly decline in decades after Anthropic released a tool aimed at modernizing a programming language used on IBM mainframes.
That mattered because it touched one of the market’s most sensitive questions around the company: whether AI can make older enterprise systems easier to replace, simplify workloads that once required specialized IBM-linked expertise, or reduce the stickiness of parts of the legacy stack.
That does not mean IBM’s franchise is disappearing. But it does explain why investors are reacting so sharply to any quarter that does not clearly prove the opposite.
IBM Is Trying To Sell A Different Story
To its credit, IBM is not standing still.
The company has spent years reshaping itself around hybrid cloud, enterprise software, and infrastructure that management believes should remain relevant in an AI-heavy environment. The acquisition history matters here:
- Red Hat
- HashiCorp
- Confluent
Those deals were all part of a broader effort to move IBM away from a more traditional legacy-tech profile and toward a more modern enterprise platform story.
That matters because investors are not only judging IBM on what it was. They are judging it on whether that repositioning is working fast enough.
The Market Wants Proof, Not Just Positioning
That is really the main takeaway from this reaction.
IBM may have a credible strategic narrative around AI, hybrid cloud, and enterprise modernization. But the market is no longer satisfied with narrative alone. It wants proof in the numbers.
That means investors are looking for:
- stronger software growth
- more stable consulting performance
- clearer benefits from acquisitions
- and guidance that feels confident, not merely adequate
This quarter did not fully deliver that combination.
This Was Also A Sector Read-Through
The stock move also says something bigger about the software group.
When a company like IBM sells off this hard after a mixed-but-not-disastrous quarter, it usually means the sector is already trading with a short leash. Investors are quick to punish anything that looks cautious, especially when AI is making them question the durability of older business models.
That is why the weakness in ServiceNow, Oracle, and IBM matters as a group. It suggests parts of the market are still trying to sort out which software companies will truly benefit from AI and which ones may be more exposed to disruption than they appear.
WSA Take
IBM’s quarter was not a disaster, but it was not the kind of report that could reset the market’s anxiety around AI either. Stronger software growth helped, but a consulting miss and cautious guidance left too much room for investors to stay skeptical.
For investors, the key issue is simple: IBM still has to prove that AI is a tailwind to its transformation, not a threat to the stability of its older businesses. Until the numbers make that case more clearly, the stock may keep trading like a company caught between reinvention and disruption.
Disclaimer
WallStAccess is a financial media platform providing market commentary and analysis for informational and educational purposes only. This content does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers should conduct their own research or consult a licensed financial professional before making investment decisions.
